Document:

EX-10.7

 Exhibit 10.7 

GYROSCOPE THERAPEUTICS HOLDINGS PLC 

2021 EMPLOYEE SHARE PURCHASE PLAN 

The purpose of the Gyroscope Therapeutics Holdings plc 2021 Employee Share Purchase Plan (the “Plan”) is to provide eligible
employees of Gyroscope Therapeutics Holdings plc (the “Company”) and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase Ordinary Shares or the number of American Depositary Shares, representing
Ordinary Shares on deposit with a U.S. banking institution selected by the Company and which are registered pursuant to a Form F-6, equal to an Ordinary Share (the “Shares”).
                 Shares in the aggregate have been approved and reserved for this purpose, plus on January 1, 2022 and each January 1 thereafter through
January 1, 2030, the number of Shares reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i)                 
Ordinary Shares, (ii)         percent (         %) of the number of Shares issued and outstanding on the immediately preceding December 31, or
(iii) such lesser number of Shares as determined by the Administrator; it being understood that the number of Ordinary Shares increased by this sentence shall not exceed more than
                 Ordinary Shares in the aggregate. 
 The
Plan includes two components: a Code Section 423 Component (the “423 Component”) and a non-Code Section 423 Component (the “Non-423
Component”). It is intended for the 423 Component to constitute an “employee stock purchase plan” within the meaning of Section 423(b) of the U.S. Internal Revenue Code of 1986, as amended (the “Code”),
and the 423 Component shall be interpreted in accordance with that intent. Under the Non-423 Component, which does not qualify as an “employee stock purchase plan” within the meaning of
Section 423(b) of the Code, options will be granted pursuant to rules, procedures or sub-plans adopted by the Administrator designed to achieve tax, securities laws or other objectives for eligible
employees. Except as otherwise provided herein, the Non-423 Component will operate and be administered in the same manner as the 423 Component. 

Unless otherwise defined herein, capitalized terms in this Plan shall have the meaning ascribed to them in Section 11. 

1. Administration. The Plan will be administered by the person or persons (the “Administrator”) appointed by the
Company’s Board of Directors (the “Board”) for such purpose. The Administrator has authority at any time to: (i) determine the Offerings, (ii) adopt, alter and repeal such rules, guidelines and practices for the
administration of the Plan and for its own acts and proceedings as it shall deem advisable; (iii) interpret the terms and provisions of the Plan; (iv) make all determinations it deems advisable for the administration of the Plan, including
to accommodate the specific requirements of local laws, regulations and procedures for jurisdictions outside the United States; (v) decide all disputes arising in connection with the Plan; and (vi) otherwise supervise the administration of
the Plan. All interpretations and decisions of the Administrator shall be binding on all persons, including the Company and the Participants. No member of the Board or individual exercising administrative authority with respect to the Plan shall be
liable for any action or determination made in good faith with respect to the Plan or any option granted hereunder. 

 2. Offerings. The Company will make one or more offerings to eligible employees to
purchase Shares under the Plan (“Offerings”) consisting of one or more Purchase Periods. Unless otherwise determined by the Administrator, the initial Offering will begin on a date determined by the Board and will end six
(6) months from such date. Thereafter, unless otherwise determined by the Administrator, an Offering will begin on a date determined by the Board and will end six (6) months from such date. The Administrator may, in its discretion,
designate a different period for any Offering, provided that no Offering shall exceed twenty-seven (27) months in duration or overlap with any other Offering. 

3. Eligibility. All individuals classified as employees on the payroll records of the Company and each Designated Subsidiary are
eligible to participate in any one or more of the Offerings under the Plan; provided that, unless otherwise determined by the Administrator, as of the first day of the applicable Offering (the “Offering Date”) they are
customarily employed by the Company or a Designated Subsidiary for more than twenty (20) hours a week and have completed at least thirty (30) days of employment. Notwithstanding any other provision herein, individuals who are not
contemporaneously classified as employees of the Company or a Designated Subsidiary for purposes of the Company’s or applicable Designated Subsidiary’s payroll system are not considered to be eligible employees of the Company or any
Designated Subsidiary and shall not be eligible to participate in the Plan. In the event any such individuals are reclassified as employees of the Company or a Designated Subsidiary for any purpose, including, without limitation, common law or
statutory employees, by any action of any third party, including, without limitation, any government agency, or as a result of any private lawsuit, action or administrative proceeding, such individuals shall, notwithstanding such reclassification,
remain ineligible for participation, unless such individuals are required to be eligible to participate in the Plan pursuant to applicable law. Notwithstanding the foregoing, the exclusive means for individuals who are not contemporaneously
classified as employees of the Company or a Designated Subsidiary on the Company’s or Designated Subsidiary’s payroll system to become eligible to participate in this Plan is through an amendment to this Plan, duly executed by the Company,
which specifically renders such individuals eligible to participate herein. 
 4. Participation. 

An eligible employee may participate in an Offering by submitting an enrollment form (which may be in electronic format) to his or her
appropriate payroll location at least fifteen (15) business days before the Offering Date (or by such other deadline as shall be established by the Administrator for the Offering). The enrollment form will (a) state a whole percentage or
the amount to be deducted from an eligible employee’s Compensation (as defined in Section 11) per pay period, (b) authorize the purchase of Shares in each Offering in accordance with the terms of the Plan and (c) specify the
exact name or names in which Shares purchased for such individual are to be issued pursuant to Section 10. An employee who does not enroll in accordance with these procedures will be deemed to have waived the right to participate. Unless a
Participant files a new enrollment form or withdraws from the Plan, such Participant’s deductions and purchases will continue at the same percentage or amount of Compensation for future Offerings, provided he or she remains eligible.
Notwithstanding the foregoing, participation in the Plan will neither be permitted nor be denied contrary to the requirements of the Code. 

 5. Employee Contributions. Each eligible employee may authorize payroll deductions at
a minimum of one percent (1%) up to a maximum of fifteen percent (15%) of such employee’s Compensation for each pay period. The Company will maintain book accounts showing the amount of payroll deductions made by each Participant for each
Purchase Period. No interest will accrue or be paid on payroll deductions, except as may be required by applicable law. If payroll deductions for purposes of the Plan are prohibited or otherwise problematic under applicable law (as determined by the
Administrator in its discretion), the Administrator may require Participants to contribute to the Plan by such other means as determined by the Administrator. Any reference to “payroll deductions” in this Section 5 (or in any other
section of the Plan) will similarly cover contributions by other means made pursuant to this Section 5. 
 6. Deduction Changes.
Except as may be determined by the Administrator in advance of an Offering, a Participant may not increase or decrease his or her payroll deduction during any Offering, but may increase or decrease his or her payroll deduction with respect to the
next Offering (subject to the limitations of Section 5) by filing a new enrollment form at least fifteen (15) business days before the next Offering Date (or by such other deadline as shall be established by the Administrator for the
Offering). The Administrator may, in advance of any Offering, establish rules permitting a Participant to increase, decrease or terminate his or her payroll deduction during an Offering. 

7. Withdrawal. A Participant may withdraw from participation in the Plan at any time prior to the end of an Offering by delivering a
written notice of withdrawal to the Company in accordance with such procedures as may be established. The Participant’s withdrawal will be effective as of the next business day. Following a Participant’s withdrawal, the Company will
promptly refund such individual’s entire account balance under the Plan to him or her (after payment for any Shares purchased before the effective date of withdrawal). Partial withdrawals are not permitted. Such an employee may not begin
participation again during the remainder of the Offering, but may enroll in a subsequent Offering in accordance with Section 4. 
 8.
Grant of Options. On each Offering Date, the Company will grant to each eligible employee who is then a Participant in the Plan an option (“Option”) to purchase on the last day of a Purchase Period (the “Exercise
Date”), at the Option Price hereinafter provided for, the lowest of (a) a number of shares of Common Stock determined by dividing such Participant’s accumulated payroll deductions on such Exercise Date by the Option Price (as
defined herein), (b) such maximum number of shares as shall have been established by the Administrator in advance of the Offering; provided, however, that such Option shall be subject to the limitations set forth below. Each
Participant’s Option shall be exercisable only to the extent of such Participant’s accumulated payroll deductions on the Exercise Date. The purchase price for each share purchased under each Option (the “Option Price”)
will be eighty-five percent (85%) of the Fair Market Value of the Shares on the Offering Date or the Exercise Date, whichever is less. 

Notwithstanding the foregoing, no Participant may be granted an Option hereunder if such Participant, immediately after the Option was
granted, would be treated as owning shares possessing five percent (5%) or more of the total combined voting power or value of all classes of shares of the Company or any Parent or Subsidiary (as defined in Section 11). For purposes of the
preceding sentence, the attribution rules of Section 424(d) of the Code shall apply in determining the share ownership of a Participant, and all shares which the Participant has a 

 
contractual right to purchase shall be treated as shares owned by the Participant. In addition, no Participant may be granted an Option which permits his or her rights to purchase Shares under
the Plan, and any other employee share purchase plan of the Company and its Designated Subsidiaries, to accrue at a rate which exceeds twenty-five thousand dollars ($25,000) of the fair market value of such Shares (determined on the Option grant
date or dates) for each calendar year in which the Option is outstanding at any time. The purpose of the limitation in the preceding sentence is to comply with Section 423(b)(8) of the Code and shall be applied taking Options into account in
the order in which they were granted. 
 9. Exercise of Option and Purchase of Shares. Each employee who continues to be a
Participant in the Plan on the Exercise Date shall be deemed to have exercised his or her Option on such date and shall acquire from the Company such number of whole Shares reserved for the purpose of the Plan as his or her accumulated payroll
deductions on such date will purchase at the Option Price, subject to any other limitations contained in the Plan. Any amount remaining in a Participant’s account at the end of a Purchase Period solely by reason of the inability to purchase a
fractional share will be carried forward to the next Purchase Period and, if such Exercise Date is the final Exercise Date of an Offering, will be carried forward to the next Offering; any other balance remaining in a Participant’s account at
the end of an Offering for any other reason will be refunded to the Participant promptly. 
 10. Issuance of Certificates. Shares
purchased under the Plan will be registered only in the name of the employee, in the name of the employee and another person of legal age as joint tenants with rights of survivorship, or in the name of a broker authorized by the employee to be his,
her or their, nominee for such purpose. The Company will not be required to deliver to any certificates evidencing Shares and instead such Shares may be recorded in the books of the Company (or, as applicable, its transfer agent or stock plan
administrator). 
 11. Definitions. For the purposes of the Plan, the following terms shall be defined as set forth below: 

“Compensation” means the amount of base pay, prior to salary reduction pursuant to Sections 125, 132(f)
or 401(k) of the Code, but excluding overtime, commissions, incentive or bonus awards, allowances and reimbursements for expenses such as relocation allowances or travel expenses, income or gains on the exercise of Company share options and similar
items. 
 “Designated Subsidiary” means any present or future Subsidiary that has been designated by the
Administrator to participate in the Plan. The Administrator may so designate any Subsidiary, or revoke any such designation, at any time and from time to time, either before or after the Plan is approved by the stockholders, and may further
designate such companies or Participants as participating in the 423 Component or the Non-423 Component. The Administrator may also determine which eligible employees may be excluded from participation in the
Plan, to the extent consistent with Section 423 of the Code or as implemented under the Non-423 Component, and determine which Designated Subsidiaries will participate in separate Offerings (to the extent
that the Company makes separate Offerings). For purposes of the 423 Component, only the Company and its Subsidiaries may be Designated Subsidiaries; provided, however, that, at any given time, a Subsidiary that is a Designated Subsidiary
under the 423 Component will not be a Designated Subsidiary under the Non-423 Component. 

 “Fair Market Value of the Shares” means, as of any date,
the value of Shares determined as follows: (i) if the Shares are listed on any established stock exchange the closing sales price for Shares as quoted on such exchange for the last day preceding such date during which a sale occurred, as
reported in The Wall Street Journal or another source the Administrator deems reliable; (ii) if the Shares are not traded on a stock exchange but are quoted on a national market or other quotation system, the closing sales price on the last
date preceding such date during which a sale occurred, as reported in The Wall Street Journal or another source the Administrator deems reliable; or (iii) without an established market for the Shares, the Administrator will determine the Fair
Market Value in its discretion in accordance with applicable laws. 
 “Parent” means a “parent
corporation” with respect to the Company, as defined in Section 424(e) of the Code. 

“Participant” means an individual who is eligible as determined in Section 3 and who has complied with
the provisions of Section 4. 
 “Purchase Period” means a period of time specified within an Offering
beginning on the Offering Date or on the next day following an Exercise Date within an Offering and ending on an Exercise Date. An Offering may consist of one or more Purchase Periods. 

“Registration Date” means the date upon which the registration statement on
Form F-1 that is filed by the Company with respect to its initial public offering is declared effective by the U.S. Securities and Exchange Commission. 

“Subsidiary” means a “subsidiary corporation” with respect to the Company, as defined in
Section 424(f) of the Code. 
 12. Rights on Termination of Employment. If a Participant’s employment terminates for any
reason before the Exercise Date for any Offering, no payroll deduction will be taken from any pay due and owing to the Participant and the balance in the Participant’s account will be paid to such Participant or, in the case of such
Participant’s death, to his or her designated beneficiary as if such Participant had withdrawn from the Plan under Section 7. In the case of Participants who are employed in the UK, the termination date of their employment will be the date
they give, or are given, notice of termination of their employment unless the Administrator decides that it shall be a later date before the statutory or contractual expiry date of their notice period. An employee will be deemed to have terminated
employment, for this purpose, if the corporation that employs him or her, having been a Designated Subsidiary, ceases to be a Subsidiary, or if the employee is transferred to any corporation other than the Company or a Designated Subsidiary. Unless
otherwise determined by the Administrator, a Participant whose employment transfers between, or whose employment terminates with an immediate rehire (with no break in service) by the Company or a Designated Subsidiary, will not be treated as having
terminated employment for purposes of participating in the Plan or an Offering; provided,  

 
however, that, if a Participant transfers from an Offering under the 423 Component to an Offering under the Non-423 Component, the exercise of the
Participant’s Option will be qualified under the 423 Component only to the extent that such exercise complies with Section 423 of the Code. If a Participant transfers from an Offering under the
Non-423 Component to an Offering under the 423 Component, the exercise of the Participant’s Option will remain non-qualified under the Non-423 Component. An employee will not be deemed to have terminated employment for this purpose, if the employee is on an approved leave of absence for military service or sickness or for any other purpose approved
by the Company, if the employee’s right to reemployment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator otherwise provides in writing. 

If a Participant ceases to be employed by the Company or any Designated Subsidiary for any reason whatsoever (including as a result of being
wrongfully or unfairly dismissed) he or she shall not be entitled, and by participating in this Plan he or she shall be deemed to have waived any possible entitlement, to any sum or benefit accrued or in prospect as a result of that participation
and no such loss or curtailment shall form part of any claim for damages for breach of the Participant’s contract of employment or compensation for dismissal or any other claim whatsoever. 

13. Special Rules and Sub-Plans. Notwithstanding anything herein to the contrary, the
Administrator may adopt special rules or sub-plans applicable to the employees of a particular Designated Subsidiary, whenever the Administrator determines that such rules are necessary or appropriate for the
implementation of the Plan in a jurisdiction where such Designated Subsidiary has employees, regarding, without limitation, eligibility to participate in the Plan, handling and making of payroll deductions or contributions by other means,
establishment of bank or trust accounts to hold payroll deductions, payment of interest, conversion of local currency, obligations to pay payroll tax, withholding procedures and handling of share issuances, any of which may vary according to
applicable requirements; provided that, if such special rules or sub-plans are inconsistent with the requirements of Section 423(b) of the Code, the employees subject to such special rules or sub-plans will participate in the Non-423 Component. 
 14.
Optionees Not Shareholders. Neither the granting of an Option to a Participant nor the deductions from his or her pay shall constitute such Participant a holder of the Shares covered by an Option under the Plan until such Shares have been
purchased by and issued to him or her. No Participant shall have voting rights in Shares that he or she may purchase until such Shares have actually been purchased and issued by the Participant. 

15. Rights Not Transferable. Rights under the Plan are not transferable by a Participant other than by will or the laws of descent and
distribution, and are exercisable during the Participant’s lifetime only by the Participant. 
 16. Application of Funds. All
funds received or held by the Company under the Plan may be combined with other corporate funds and may be used for any corporate purpose. 

 17. Adjustment in Case of Changes Affecting Shares and Transactions. 

 

	 	(a)	 If any change is made in the Shares, or subject to any Option under the Plan, without the receipt of
consideration by the Company by way of any (i) variation in the ordinary share capital of the Company by way of capitalisation of profits or reserves or by way of rights or any consolidation or
sub-division or reduction of capital or otherwise; (ii) any demerger, distribution, dividend in specie or super dividend; or (iii) other corporate event which in the reasonable opinion of the Board
justifies an adjustment, the Plan will be appropriately adjusted in the class(es) and maximum number of Shares subject to the Plan and the share limitation subject to Section 8, if any, and the outstanding Options will be appropriately adjusted
in the class(es), number of Shares and share limitations of such outstanding Options. The Board shall make such adjustments, and its determination shall be final, binding and conclusive. (The conversion of any convertible securities of the Company
shall not be treated as a transaction that does not involve the receipt of consideration by the Company.) 

  

	 	(b)	 Without limitation on the preceding provisions, in the event of any corporate transaction, the Board may make
such adjustment it deems appropriate to prevent dilution or enlargement of rights in the number and class of Shares which may be delivered under the Plan, in the number, class of or Option Price available for purchase under the Plan and in the
number of the Shares which an employee is entitled to purchase and any other adjustments it deems appropriate. Without limiting the Board’s authority under this Plan, in the event of any transaction, the Board may elect to have the Options
hereunder assumed or such Options substituted by a successor entity, to terminate all outstanding Options, either prior to their expiration or upon completion of the purchase of Shares on the next Exercise Date, to shorten the Offering by setting a
new Exercise Date or to take such other action deemed appropriate by the Board. 

 18. Amendment of the Plan. The
Board may at any time and from time to time amend the Plan in any respect, except that, without the approval within twelve (12) months of such Board action by the shareholders, no amendment shall be made increasing the number of Shares approved
for the Plan or making any other change that would require shareholder approval in order for the Plan, as amended, to qualify as an “employee stock purchase plan” under Section 423(b) of the Code. 

19. Insufficient Shares. If the total number of Shares that would otherwise be purchased on any Exercise Date plus the number of Shares
purchased under previous Offerings under the Plan exceeds the maximum number of Shares issuable under the Plan, the Shares then available shall be apportioned among Participants in proportion to the amount of payroll deductions accumulated on behalf
of each Participant that would otherwise be used to purchase Shares on such Exercise Date. 
 20. Termination of the Plan. The Plan
may be terminated at any time by the Board. Upon termination of the Plan, all amounts in the accounts of Participants shall be promptly refunded. 

 21. Governmental Regulations. The Company’s obligation to sell and deliver
Shares under the Plan is subject to obtaining all governmental approvals required in connection with the authorization, issuance, or sale of such Shares. 

22. Governing Law. This Plan and all Options and actions taken thereunder shall be governed by, and construed in accordance with, the
law of England and Wales, applied without regard to conflict of law principles. 
 23. Issuance of Shares. Shares may be issued upon
exercise of an Option from authorized but unissued Shares, from Shares held in the treasury of the Company, or from any other proper source. 

24. Tax Withholding. Participation in the Plan is subject to any minimum required tax withholding on income of the Participant in
connection with the Plan. Each Participant agrees, by entering the Plan, that the Company and its Subsidiaries shall have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant, including Shares issuable
under the Plan. For this purpose “tax” shall mean Federal, state and local taxes and social security taxes in the US, and their equivalent in any other jurisdiction, for which a Participant is liable by reason of the acquisition, holding
or disposal of Shares under the Plan or the receipt of any other benefit in connection with it and which the Company or any Subsidiary is liable to account for on the Participant’s behalf. 

25. Notification Upon Sale of Shares. Each Participant agrees, by entering the 423 Component of the Plan, to provide if requested by
the Company prompt notice of any disposition of shares purchased under the Plan where such disposition occurs within two years after the date of grant of the Option pursuant to which such shares were purchased or within one year after the date such
shares were purchased. 
 26. Effective Date and Approval of Shareholders. The Plan shall, subject to shareholder approval in
accordance with applicable law, take effect upon the date immediately preceding the Registration Date. 

 APPENDIX A 

Designated SubsidiariesEX-10.8

 Exhibit 10.8 

DEED OF INDEMNITY 
 THIS DEED OF
INDEMNITY is made on [●] April 2021 
 BETWEEN 
  

							
	(1)	 	GYROSCOPE THERAPEUTICS HOLDINGS LIMITED a company registered in England and Wales (registered number 13086765) whose registered office is at Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage SG1 2FX (the
“Company”); and
				
	(2)	 	[●] of	 	 	 	
			
		 	 	 	(Insert Address)
			
		 	(the “Director”).	 	

 Now THIS DEED WITNESSED as follows: 
  

	1.	 Subject to the terms of this Deed, the Company shall, to the fullest extent permitted by law and without
prejudice to any other indemnity to which the Director may otherwise be entitled, indemnify and hold the Director harmless in respect of all claims, actions and proceedings, whether civil, criminal or regulatory (“Claims”), and any
losses, damages, penalties, liabilities, compensation or other awards arising in connection with any such Claims (“Losses”), whether instigated, imposed or incurred under the laws of England and Wales or the law of any other
jurisdiction and arising out of, or in connection with, the actual or purported exercise of, or failure to exercise, any of the Director’s powers, duties or responsibilities as a director or officer of the Company or any of its subsidiaries (as
defined in section 1159 and Schedule 6 of the Act) for the time being (together referred to in this Deed as “Group Companies”), subject to the remaining provisions of this Deed. In this Deed the “Act” means the
Companies Act 2006 including any modification or re-enactment of it for the time being in force. 

  

	2.	 The indemnity in clause 1 of this Deed shall be deemed not to provide for, or entitle the Director to, any
indemnification that would cause this Deed, or any part of it, to be treated as void under the Act and, in particular, to the extent the liability attaches to the Director in connection with any negligence, default, breach of duty or breach of trust
in relation to the company of which he is a director, shall not provide directly or indirectly (to any extent) any indemnity against: 

  

	 	(a)	 any liability incurred by the Director to the Company or any associated company (as defined in section 256 of
the Act) (each, an “Associated Company”); or 

  

	 	(b)	 any liability incurred by the Director to pay a fine imposed in criminal proceedings or a sum payable to a
regulatory authority by way of a penalty in respect of non-compliance with any requirement of a regulatory nature; or 

  

	 	(c)	 any liability incurred by the Director: 

 

	 	(i)	 in defending any criminal proceedings in which he is convicted; or 

 

	 	(ii)	 in defending any civil proceedings brought by the Company, or an Associated Company, in which final judgment
(within the meaning set out in section 234 of the Act) is given against him; or 

	 	(iii)	 in connection with any application under section 661(3) or section 661(4) or section 1157 of the Act (as the
case may be) for which the court refuses to grant him relief, 

 save that, in respect of a provision indemnifying a
director of a company (whether or not the Company) that is a trustee of an occupational pension scheme (as that term is used in section 235 of the Act) against liability incurred in connection with that company’s activities as trustee of the
scheme, the Company shall also be able to indemnify any such director without the restrictions in subclauses (a), (i) and (iii) applying; 

and where, in any such case, any such conviction, judgment or refusal of relief has become final. 

Reference in this clause 2 to a conviction, judgment or refusal of relief becoming final shall be construed in accordance with section 234(5)
of the Act. 
  

	3.	 Without prejudice to the generality of and in addition to the indemnity set out in clause 1 of this Deed, the
Company shall, to the fullest extent permitted by law, indemnify and hold the Director harmless on an ‘as incurred’ basis against all legal and other costs, charges and expenses reasonably incurred: 

 

	 	(a)	 in defending Claims including, without limitation, Claims brought by, or at the request of, the Company or any
Associated Company; 

  

	 	(b)	 in defending himself in any investigation into the affairs of the Company or any of its subsidiaries by any
judicial, governmental, regulatory or other body or against any action proposed to be taken by any such authority; and 

  

	 	(c)	 in connection with any application under section 661(3) or section 661(4) or section 1157 of the Act,

 provided that, in accordance with section 234 of the Act, the Director agrees that the indemnity provided for in this
clause 3 shall not extend to any such legal and other costs, charges and expenses incurred by the Director: 
  

	 	(i)	 in defending criminal proceedings in which he is convicted; or 

 

	 	(ii)	 in defending civil proceedings brought by the Company or an Associated Company in which judgment is given
against him; or 

  

	 	(iii)	 in connection with an application for relief which is refused, and any monies paid by the Company in respect of
the indemnity in this clause 3 shall fall to be repaid not later than: 

  

	 	(A)	 in the event of the Director being convicted in the proceedings, the date when the conviction becomes final; or

  

	 	(B)	 in the event of judgment being given against the Director in the proceedings, the date when the judgment
becomes final; or 

  

	 	(C)	 in the event of the court refusing to grant the Director relief on the application, the date when the refusal
of relief becomes final. 

  
 2 

 References in this clause 3 to a conviction, judgment or refusal of relief being
‘final’ shall be construed in accordance with section 234(5) of the Act. 
  

	4.	 The Company shall (at the cost of the Company) effect and maintain appropriate directors’ and
officers’ liability insurance on terms no less favourable than the existing directors’ and officers’ liability insurance of the Company at the date of this Deed (including ensuring that premiums are properly paid in full by the due
date) for the benefit of the Director for so long as any Claims may lawfully be brought against the Director in respect of the period whilst he has been a director. 

 

	5.	 The Director shall: 

  

	 	(a)	 give written notice to the Company upon receipt of any demand relating to any Claims (or circumstances which
may reasonably be expected to give rise to a demand relating to Claims; and 

  

	 	(b)	 to the extent permitted by law: 

 

	 	(i)	 give full details and providing copies of all relevant correspondence; and 

 

	 	(ii)	 keep the Company informed of all material developments in the progress of any Claims, including providing all
such information in relation to any Claims or Losses or any other costs, charges or expenses incurred as the Company may reasonably request. 

  

	6.	 If a company ceases to be a Group Company after the date of this Deed, the Company shall only be liable to
indemnify the Director in respect of liabilities in relation to that company which arose before the date on which that company ceased to be a Group Company. 

  

	7.	 The Director of any company which becomes a Group Company after the date of this Deed shall be indemnified only
in respect of liabilities arising after the date on which that company became a Group Company. 

  

	8.	 All sums payable by the Company hereunder shall be paid free and clear of any setoff, deduction, withholding or
counterclaim on any account whatsoever, save only as may be required by law. If any deduction or withholding is required by law, then the Company shall be obliged to pay to the Director such amount as will ensure that after such deduction or
withholding has been made, the Director receives a sum equal to the amount that he would otherwise have received in the absence of such deduction or withholding. 

 

	9.	 This Deed shall remain in force until such time as any relevant limitation periods for bringing Claims against
the Director have expired, or for so long as the Director remains liable for any Losses. 

  

	10.	 If this Deed is finally judicially determined in a relevant jurisdiction to provide for, or entitle the
Director to, indemnification against any Claims or Losses that would cause this Deed, or any part of it, to be treated as void under the laws of that jurisdiction, this Deed shall, in so far as it relates to such jurisdiction, be deemed not to
provide for, or entitle the Director to, any such indemnification, and the Company shall instead indemnify the Director against any Claims or Losses to the fullest extent permitted by law in that jurisdiction. 

  
 3 

	11.	 The successors and personal representatives of the Director shall be entitled to the benefit of this Deed.

  

	12.	 Save as aforesaid, a person who is not a party to this Deed shall have no right under the Contracts (Rights of
Third Parties) Act 1999 to enforce any of its terms. 

  

	13.	 This Deed may be executed in any number of counterparts, and by each party on separate counterparts. Each
counterpart is an original, but all counterparts will together constitute one and the same instrument. Delivery of a counterpart of this Deed by e-mail attachment or telecopy will be an effective mode of
delivery. 

  

	14.	 This Deed and any non-contractual obligations arising out of or in
connection with it shall be governed by, and interpreted in accordance with, the laws of England and Wales and each of the Company and the Director hereby submit for all purposes in connection with this Deed to the exclusive jurisdiction of the High
Court of Justice in England and Wales. 

 [Intentionally left blank, signature pages follow.] 

  
 4 

 IN WITNESS whereof this Deed has been executed on the day and year first above written. 

 

							
	 EXECUTED and DELIVERED
	 	)	 	
	 as a DEED by Gyroscope Therapeutics
	 	)	 		 	
	 Holdings Limited
	 	)	 		 	  

	 acting by
	 	)	 		 	Signature
		 	)	 		 	
	                                      
                                      ,	 	)	 		 	
	 a director, in the presence of :
	 		 	

									
					
	 Signature:
	 	  
	 		 	Address:	 	  

					
	 Name:
	 	  
	 		 		 	  

					
		 		 		 		 	  

					
		 		 		 		 	  

  
 1 

							
	 EXECUTED and DELIVERED
	 	)	 	
	 as a DEED by [●]
	 	)	 		 	  

		 		 		 	Signature
	 in the presence of:
	 		 		 	
	                                      
                                       	 		 		 	

									
					
	 Signature:
	 	  
	 		 	Address:	 	  

					
	 Name:
	 	  
	 		 		 	  

					
		 		 		 		 	  

					
		 		 		 		 	  

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}]]